Teacher:In this task, you are given text for US Congressional and California state bills, your task is to generate a summary for this bill.
Teacher: Now, understand the problem? Solve this instance: SECTION 1. SHORT TITLE.

This Act may be cited as the ''Research on Human Fetal Tissue
Amendments of 1993''.

SEC. 2. ESTABLISHMENT OF AUTHORITIES AND PROTECTIONS REGARDING
TRANSPLANTATION OF HUMAN FETAL TISSUE.

Part G of title IV of the Public Health Service Act (42 U.S.C. 289
et seq.) is amended by inserting after section 498 the following new
section:

''research on transplantation of fetal tissue

''Sec. 498A. (a) Establishment of Program.--
''(1) In general.--The Secretary may conduct or support
research on the transplantation of human fetal tissue for
therapeutic purposes.
''(2) Source of tissue.--Human fetal tissue may be used in
research carried out under paragraph (1) regardless of whether
the tissue is obtained pursuant to a spontaneous or induced
abortion or pursuant to a stillbirth.
''(b) Informed Consent of Donor.--
''(1) In general.--In research carried out under subsection
(a), human fetal tissue may be used only if the woman providing
the tissue makes a statement, made in writing and signed by the
woman, declaring that--
''(A) the woman donates the fetal tissue for use in
research described in subsection (a);
''(B) the donation is made without any restriction
regarding the identity of individuals who may be the
recipients of transplantations of the tissue; and
''(C) the woman has not been informed of the
identity of any such individuals.
''(2) Additional statement.--In research carried out under
subsection (a), human fetal tissue may be used only if the
attending physician with respect to obtaining the tissue from
the woman involved makes a statement, made in writing and
signed by the physician, declaring that--
''(A) in the case of tissue obtained pursuant to an
induced abortion--
''(i) the consent of the woman for the
abortion was obtained prior to requesting or
obtaining consent for the tissue to be used in
such research; and
''(ii) no alteration of the timing, method,
or procedures used to terminate the pregnancy
was made solely for the purposes of obtaining
the tissue;
''(B) the tissue has been donated by the woman in
accordance with paragraph (1); and
''(C) full disclosure has been provided to the
woman with regard to--
''(i) such physician's interest, if any, in
the research to be conducted with the tissue;
and
''(ii) any known medical risks to the woman
or risks to her privacy that might be
associated with the donation of the tissue and
that are in addition to risks of such type that
are associated with the woman's medical care.
''(c) Informed Consent of Researcher and Donee.--In research
carried out under subsection (a), human fetal tissue may be used only
if the individual with the principal responsibility for conducting the
research involved makes a statement, made in writing and signed by the
individual, declaring that the individual--
''(1) is aware that--
''(A) the tissue is human fetal tissue;
''(B) the tissue may have been obtained pursuant to
a spontaneous or induced abortion or subsequent to a
stillbirth; and
''(C) the tissue was donated for research purposes;
''(2) has provided such information to other individuals
with responsibilities regarding the research;
''(3) will require, prior to obtaining the consent of an
individual to be a recipient of a transplantation of the
tissue, written acknowledgment of receipt of such information
by such recipient; and
''(4) has had no part in any decisions as to the timing,
method, or procedures used to terminate the pregnancy made
solely for the purposes of the research.
''(d) Availability of Statements for Audit.--
''(1) In general.--In research carried out under subsection
(a), human fetal tissue may be used only if the head of the
agency or other entity conducting the research involved
certifies to the Secretary that the statements required under
subsections (b)(2) and (c) will be available for audit by the
Secretary.
''(2) Confidentiality of audit.--Any audit conducted by the
Secretary pursuant to paragraph (1) shall be conducted in a
confidential manner to protect the privacy rights of the
individuals and entities involved in such research, including
such individuals and entities involved in the donation,
transfer, receipt, or transplantation of human fetal tissue.
With respect to any material or information obtained pursuant
to such audit, the Secretary shall--
''(A) use such material or information only for the
purposes of verifying compliance with the requirements
of this section;
''(B) not disclose or publish such material or
information, except where required by Federal law, in
which case such material or information shall be coded
in a manner such that the identities of such
individuals and entities are protected; and
''(C) not maintain such material or information
after completion of such audit, except where necessary
for the purposes of such audit.
''(e) Applicability of State and Local Law.--
''(1) Research conducted by recipients of assistance.--The
Secretary may not provide support for research under subsection
(a) unless the applicant for the financial assistance involved
agrees to conduct the research in accordance with applicable
State and local law.
''(2) Research conducted by secretary.--The Secretary may
conduct research under subsection (a) only in accordance with
applicable State and local law.
''(f) Definition.--For purposes of this section, the term 'human
fetal tissue' means tissue or cells obtained from a dead human embryo
or fetus after a spontaneous or induced abortion, or after a
stillbirth.''.

SEC. 3. PURCHASE OF HUMAN FETAL TISSUE; SOLICITATION OR ACCEPTANCE OF
TISSUE AS DIRECTED DONATION FOR USE IN TRANSPLANTATION.

Part G of title IV of the Public Health Service Act, as amended by
section 2 of this Act, is amended by inserting after section 498A the
following new section:

''prohibitions regarding human fetal tissue

''Sec. 498B. (a) Purchase of Tissue.--It shall be unlawful for any
person to knowingly acquire, receive, or otherwise transfer any human
fetal tissue for valuable consideration if the transfer affects
interstate commerce.
''(b) Solicitation or Acceptance of Tissue as Directed Donation for
Use in Transplantation.--It shall be unlawful for any person to solicit
or knowingly acquire, receive, or accept a donation of human fetal
tissue for the purpose of transplantation of such tissue into another
person if the donation affects interstate commerce, the tissue will be
or is obtained pursuant to an induced abortion, and--
''(1) the donation will be or is made pursuant to a promise
to the donating individual that the donated tissue will be
transplanted into a recipient specified by such individual;
''(2) the donated tissue will be transplanted into a
relative of the donating individual; or
''(3) the person who solicits or knowingly acquires,
receives, or accepts the donation has provided valuable
consideration for the costs associated with such abortion.
''(c) Criminal Penalties for Violations.--
''(1) In general.--Any person who violates subsection (a)
or (b) shall be fined in accordance with title 18, United
States Code, subject to paragraph (2), or imprisoned for not
more than 10 years, or both.
''(2) Penalties applicable to persons receiving
consideration.--With respect to the imposition of a fine under
paragraph (1), if the person involved violates subsection (a)
or (b)(3), a fine shall be imposed in an amount not less than
twice the amount of the valuable consideration received.
''(d) Definitions.--For purposes of this section:
''(1) The term 'human fetal tissue' has the meaning given
such term in section 498A(f).
''(2) The term 'interstate commerce' has the meaning given
such term in section 201(b) of the Federal Food, Drug, and
Cosmetic Act.
''(3) The term 'valuable consideration' does not include
reasonable payments associated with the transportation,
implantation, processing, preservation, quality control, or
storage of human fetal tissue.''.

SEC. 4. REPORT BY GENERAL ACCOUNTING OFFICE ON ADEQUACY OF PROTECTIONS.

(a) In General.--With respect to research on the transplantation of
human fetal tissue for therapeutic purposes, the Comptroller General of
the United States shall conduct an audit for the purpose of
determining--
(1) whether and to what extent such research conducted or
supported by the Secretary of Health and Human Services has
been conducted in accordance with section 498A of the Public
Health Service Act (as added by section 2 of this Act); and
(2) whether and to what extent there have been violations
of section 498B of such Act (as added by section 3 of this
Act).
(b) Report.--Not later than May 19, 1995, the Comptroller General
of the United States shall complete the audit required in subsection
(a) and submit to the Congress a report describing the findings made
pursuant to the audit.
Student:
Research on Human Fetal Tissue Amendments of 1993 - Amends the Public Health Service Act to authorize and regulate research on human fetal tissue transplantation without regard to whether the tissue is obtained after a spontaneous or induced abortion or a stillbirth in accordance with State law.
Imposes criminal penalties for: (1) transferring such tissue for valuable consideration affecting interstate commerce; or (2) soliciting or receiving a directed donation.